Next-Gen Non-Invasive Diagnostics

The future of non-invasive Vitamin B12 screening.

A rapid, point-of-care diagnostic strip detecting functional B12 deficiency via urinary Methylmalonic Acid (MMA)

SensiCue Strip

Dip
Color change
Match & read
Urine
Sample
< 5 mins
Result
₹250–350
Price
The Clinical Problem

A silent epidemic — and a diagnostic accessibility gap.

Subclinical Vitamin B12 deficiency is common and consequential, yet the only routine tests are invasive, expensive and lab-bound.

47–70%

Indian adults affected

A silent epidemic across diets, ages and regions — most never know.

₹800–1000

Cost of a blood test

Invasive, lab-bound and expensive — a real barrier to repeat monitoring.

0

At-home options today

No affordable, non-invasive point-of-care way to screen or track B12.

The accessibility gap: current B12 testing requires a phlebotomist, a lab, and a 2–3 day wait. For rural clinics, elderly patients and at-home monitoring, that's a screening tool that effectively doesn't exist.

Our Solution

A paper strip. Three simple steps.

SensiCue detects urinary MMA — a functional biomarker that rises when B12 is low — using colorimetric paper chemistry. No instruments, no power, no lab.

1

Dip

Hold the strip under the urine stream.

2

Watch

A distinct colour develops on the reaction zone.

3

Match

Compare against the reference chart for your B12 status.

Non-invasive — urine, no needles
Result in under 5mins, point-of-care
₹250–350 per test (vs ₹800–1000)
Designed for repeat at-home monitoring
Milestones

From bench to bedside.

Phase 1

Proof-of-Concept

  • Colorimetric chemistry validation in synthetic urine
  • Detection range covering clinical MMA thresholds
  • Determining Sensitivity and Specificity
Phase 2

Prototype & Clinical Pilot

  • Strip optimisation for real urine samples
  • Pilot validation with partner hospital
  • Regulatory pathway scoping
Phase 3

Manufacturing & Launch

  • CDSCO regulatory submission
  • Scaled manufacturing partner onboarding
  • Commercial launch — pharmacies & at-home channels
Scientific Basis

References & further reading.

Peer-reviewed work underpinning B12 epidemiology, MMA as a functional biomarker, and diagnostic algorithms.

B12 Prevalence — India
MMA as a Functional Biomarker

Cobalamin (Vitamin B12) deficiency detection by urinary methylmalonic acid quantitation

Blood 59(6), 1982: 1128–1131.

https://www.sciencedirect.com/science/article/pii/S0006497120760222

Population reference values for serum MMA — age, sex, race-ethnicity, kidney function and B12

Ganji V, Kafai MR. Nutrients 10(1), 2018: 74.

https://pmc.ncbi.nlm.nih.gov/articles/PMC5793302/

Use of fasting urinary MMA to screen for metabolic vitamin B12 deficiency in older persons

Nutrition 20(9), 2004: 764–768.

https://www.sciencedirect.com/science/article/abs/pii/S0899900704001595

Urinary MMA as an indicator of early B12 deficiency and its role in polyneuropathy in Type 2 Diabetes

J. Diabetes Res. 2014: 921616.

https://pmc.ncbi.nlm.nih.gov/articles/PMC3955587/

Role of serum holotranscobalamin in low serum cobalamin — comparison with MMA and homocysteine

Ann. Hematol. 2013.

https://link.springer.com/article/10.1007/s00277-013-1905-z

Urine MMA measurements for assessment of cobalamin deficiency related to neuropsychiatric disorders

Clin. Biochem. 36(4), 2003: 275–282.

https://www.sciencedirect.com/science/article/abs/pii/S000991200300033X

Vitamin B12, MMA and all-cause mortality in heart failure populations (NHANES)

Front. Nutr. 12, 2025.

https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2025.1597305/full

Pseudo-Methyl Malonic Acidemia in Indian babies secondary to maternal B12 deficiency

Kumar K, Nagar N, Girish SV. J. Clin. Paediatr. Child Health Care 1(1), 2024.

https://bioresscientia.com/article/pseudo-methyl-malonic-acidemia-in-indian-babies-secondary-to-maternal-vitamin-b12-deficiency

Biomarkers and Algorithms for the Diagnosis of Vitamin B12 Deficiency

Front. Mol. Biosci. 3, 2016: 27.

https://www.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2016.00027/full

Our Team

Meet the people behind SensiCue.

SJ

Shreshta Jain

Founder & Director

M.Sc. Stem Cell & Regenerative Biology, Manipal Institute of Regenerative Medicine.

P

Padmapriya

Operations & Finance

Leading operations and accounting.

PT

Pratik Tawade

Technical Advisor

PhD Biosensing, TU Delft · M.Tech Chemical Engineering, IIT Madras.

PP

Padma Prasad

Business Advisor

30+ years in strategic partnerships and go-to-market for tech ventures.

Mentors

PV

Prof. Vedavyas

External Business Advisor

30+ years in IT strategy and entrepreneurship; ex-Senior VP, Mahindra Satyam.

DB

Dr. B. E. Pradeep

Scientific Mentor, SSSIHL

Translational biosciences, AI-enabled healthcare and point-of-care diagnostics.

DS

Dr. Shyam Vasudev Rao

External Technical Advisor

Founder, Forus Health & Renalyx Health Systems. Pioneer in medical devices.

Incubated at Sri Sathya Sai Research and Innovation Foundation · Part of the WE-BIO C-CAMP cohort.

Get in touch

Partner, pilot or invest with us.

We're looking for clinical pilot partners, manufacturing collaborators and mission-aligned investors.

jain.shreshta@sensicue.com jain.shreshta11@gmail.com